Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 16380594)

1.

Adrenoleukodystrophy: new approaches to a neurodegenerative disease.

Moser HW, Raymond GV, Dubey P.

JAMA. 2005 Dec 28;294(24):3131-4.

PMID:
16380594
2.

X-linked adrenoleukodystrophy.

Moser HW, Mahmood A, Raymond GV.

Nat Clin Pract Neurol. 2007 Mar;3(3):140-51. Review.

PMID:
17342190
3.

Therapy of X-linked adrenoleukodystrophy.

Moser HW.

NeuroRx. 2006 Apr;3(2):246-53. Review.

4.

Therapy of X-linked adrenoleukodystrophy.

Semmler A, Köhler W, Jung HH, Weller M, Linnebank M.

Expert Rev Neurother. 2008 Sep;8(9):1367-79. doi: 10.1586/14737175.8.9.1367. Review.

PMID:
18759549
5.

"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV.

J Mol Neurosci. 2007 Sep;33(1):105-13. Review.

PMID:
17901554
6.

Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

Moser HW.

J Neuropathol Exp Neurol. 1995 Sep;54(5):740-5. Review.

PMID:
7666063
7.

The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.

Al-Omar MA.

J Herb Pharmacother. 2006;6(3-4):125-34. Review.

PMID:
17317654
8.

X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients.

Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox CS, Lu SE.

Neuropediatrics. 2000 Oct;31(5):227-39. Review.

PMID:
11204280
9.

[Endocrine disease in adrenoleukodystrophy].

Girard S, Bruckert E, Turpin G.

Ann Med Interne (Paris). 2001 Feb;152(1):15-26. Review. French.

PMID:
11240421
10.

Progress in X-linked adrenoleukodystrophy.

Moser H, Dubey P, Fatemi A.

Curr Opin Neurol. 2004 Jun;17(3):263-9. Review.

PMID:
15167059
11.

Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.

Moser HW.

J Inherit Metab Dis. 1995;18(4):435-47. Review.

PMID:
7494402
12.

Dietary management of X-linked adrenoleukodystrophy.

Moser HW, Borel J.

Annu Rev Nutr. 1995;15:379-97. Review.

PMID:
8527226
13.

[X-linked adrenoleukodystrophy (ALD)].

Imamura A, Suzuki Y.

Nihon Rinsho. 2004 Jan;62 Suppl:389-92. Review. Japanese. No abstract available.

PMID:
15011392
14.

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

van Geel BM, Assies J, Wanders RJ, Barth PG.

J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):4-14. Review.

15.

Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Berger J, Pujol A, Aubourg P, Forss-Petter S.

Brain Pathol. 2010 Jul;20(4):845-56. doi: 10.1111/j.1750-3639.2010.00393.x. Review.

16.

Adrenoleukodystrophy.

Moser HW, Bergin A, Naidu S, Ladenson PW.

Endocrinol Metab Clin North Am. 1991 Jun;20(2):297-318. Review.

PMID:
1879401
17.

[X-linked adrenoleukodystrophy].

Aubourg P.

Ann Endocrinol (Paris). 2007 Dec;68(6):403-11. Epub 2007 May 29. Review. French.

PMID:
17532287
18.

[Diet therapy in the treatment of neuropediatric disorders].

Chaves-Carballo E.

Rev Neurol. 2003 Aug 1-15;37(3):267-74. Review. Spanish.

19.

[Very long chain fatty acids in the pathogenesis, prenatal and postnatal diagnosis of X-linked adrenoleukodystrophy].

Grković S, Dordević M, Nikolić R, Zivancević-Simonović S, Puzigaća Z.

Med Pregl. 2007 Jul-Aug;60(7-8):401-3. Review. Serbian.

PMID:
17990810
20.

Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil.

Moser HW, Powers JM, Smith KD.

Brain Pathol. 1995 Jul;5(3):259-66. Review.

PMID:
8520725
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk